Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC

吉非替尼 基因敲除 奥西默替尼 癌症研究 氮氧化物4 表皮生长因子受体 下调和上调 生物 医学 NADPH氧化酶 细胞生物学 受体 内科学 细胞培养 埃罗替尼 基因 活性氧 生物化学 遗传学
作者
Wenjing Liu,Lin Wang,Feng-Mei Zhou,Shuwen Liu,Wei Wang,Erjiang Zhao,Quan-Jun Yao,Wei Li,Yanqiu Zhao,Zhi Shi,Jian-Ge Qiu,Bing‐Hua Jiang
出处
期刊:Drug Resistance Updates [Elsevier BV]
卷期号:70: 100987-100987 被引量:60
标识
DOI:10.1016/j.drup.2023.100987
摘要

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for human non-small-cell lung cancer (NSCLC) treatment. However, acquired resistance to EGFR-TKIs is the major barrier of treatment success, and new resistance mechanism remains to be elucidated. In this study, we found that elevated NADPH oxidase 4 (NOX4) expression was associated with acquired EGFR-TKIs resistance. Gefitinib is the first-generation FDA-approved EGFR-TKI, and osimertinib is the third-generation FDA-approved EGFR-TKI. We demonstrated that NOX4 knockdown in the EGFR-TKI resistant cells enabled the cells to become sensitive to gefitinib and osimertinib treatment, while forced expression of NOX4 in the sensitive parental cells was sufficient to induce resistance to gefitinib and osimertinib in the cells. To elucidate the mechanism of NOX4 upregulation in increasing TKIs resistance, we found that knockdown of NOX4 significantly down-regulated the expression of transcription factor YY1. YY1 bound directly to the promoter region of IL-8 to transcriptionally activate IL-8 expression. Interestingly, knockdown of NOX4 and IL-8 decreased programmed death ligand 1 (PD-L1) expression, which provide new insight on TKIs resistance and immune escape. We found that patients with higher NOX4 and IL-8 expression levels showed a shorter survival time compared to those with lower NOX4 and IL-8 expression levels in response to the anti-PD-L1 therapy. Knockdown of NOX4, YY1 or IL-8 alone inhibited angiogenesis and tumor growth. Furthermore, the combination of NOX4 inhibitor GKT137831 and gefitinib had synergistic effect to inhibit cell proliferation and tumor growth and to increase cellular apoptosis. These findings demonstrated that NOX4 and YY1 were essential for mediating the acquired EGFR-TKIs resistance. IL-8 and PD-L1 are two downstream targets of NOX4 to regulate TKIs resistance and immunotherapy. These molecules may be used as potential new biomarkers and therapeutic targets for overcoming TKIs resistance in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
ywg完成签到 ,获得积分10
刚刚
1秒前
华仔的应助被高瑛键采纳,获得10
1秒前
科研通AI6.2的应助被Heimdall采纳,获得30
2秒前
搞怪的老九的应助被大头人参采纳,获得10
2秒前
风趣冬瓜发布了新的文献求助10
2秒前
dxftx发布了新的文献求助10
2秒前
3秒前
Dyying发布了新的文献求助10
3秒前
小马甲的应助被青阳子采纳,获得10
5秒前
zombie发布了新的文献求助10
5秒前
Savananh_Xie发布了新的文献求助10
5秒前
科研通AI6.4的应助被平生采纳,获得10
7秒前
liu完成签到 ,获得积分10
7秒前
7秒前
7秒前
womujk发布了新的文献求助10
7秒前
Akim的应助被AAA采纳,获得10
7秒前
captainHc发布了新的文献求助100
7秒前
李健的应助被dxftx采纳,获得10
8秒前
房子完成签到,获得积分10
9秒前
9秒前
乐乐的应助被sfliufighting采纳,获得10
10秒前
领导范儿的应助被冷冷子采纳,获得80
10秒前
香蕉觅云的应助被EstAffectus采纳,获得30
11秒前
CodeCraft的应助被EstAffectus采纳,获得30
11秒前
李健的应助被EstAffectus采纳,获得10
11秒前
11秒前
桐桐的应助被EstAffectus采纳,获得10
11秒前
NexusExplorer的应助被EstAffectus采纳,获得30
11秒前
搜集达人的应助被EstAffectus采纳,获得10
12秒前
李健的应助被EstAffectus采纳,获得10
12秒前
李爱国的应助被EstAffectus采纳,获得30
12秒前
12秒前
所所的应助被EstAffectus采纳,获得10
12秒前
烟花的应助被EstAffectus采纳,获得10
12秒前
房子发布了新的文献求助10
12秒前
hc发布了新的文献求助10
13秒前
鸽子二号完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573478
关于积分的说明 21831914
捐赠科研通 7781737
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962